Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk

Figure 5 SHAP summary dot plot. The probability of metabolic-associated fatty liver disease development increases with the SHAP value of a feature. A dot is made for SHAP value in the model for each single patient, so each patient has one dot on the line for each feature. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; TG: Triglyceride; A/G: Albumin/globulin.